Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900055 · ClinicalTrials.gov registry record
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- 213
- Enrollment target
NCT00900055 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 213 participants.
The verdict
NCT00900055 has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
Study Summary
RATIONALE: Analyzing tissue and blood samples from healthy volunteers or patients with Fanconi anemia, myelodysplasia, myeloproliferative disorders, or myeloma in the laboratory may help doctors learn more about the causes of blood cancers. PURPOSE: The purpose of this study is to analyze in the laboratory blood and bone marrow cells from healthy volunteers or patients with Fanconi anemia, myeloproliferative disorders, or myeloma.
Interventions
- GENETIC microarray analysis
- GENETIC protein expression analysis
- GENETIC polymerase chain reaction
- GENETIC reverse transcriptase-polymerase chain reaction
- GENETIC polyacrylamide gel electrophoresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 1975-06 |
| Est. Completion | 2016-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900055
The ClinicalTrials.gov registry entry for NCT00900055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which microarray analysis is the first listed.
NCT00900055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900055 about?
NCT00900055 is a clinical study titled "Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma". RATIONALE: Analyzing tissue and blood samples from healthy volunteers or patients with Fanconi anemia, myelodysplasia, myeloproliferative disorders, or myeloma in the laboratory may help doctors learn more about the causes of blood cancers. PURPOSE: The purpose of this study is to analyze in the la...
What is the current status of trial NCT00900055?
This trial is currently completed. The enrollment target is 213 participants. The study started on 1975-06. Estimated completion is 2016-08-23.
What interventions are being tested in trial NCT00900055?
The interventions under investigation include: microarray analysis (GENETIC), protein expression analysis (GENETIC), polymerase chain reaction (GENETIC), reverse transcriptase-polymerase chain reaction (GENETIC), polyacrylamide gel electrophoresis (GENETIC).
Who is sponsoring clinical trial NCT00900055?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.